Dr Richard Gilbertson Dr Jackie Langdon Roberto Hernan Professor Steven Clifford
| Mutational analysis of PDGFR-RAS/MAPK pathway activation in childhood medulloblastoma | 2006 |
|
Dr Adrian Frank Roberto Hernan Dr Janet Lindsey Dr Meryl Lusher Professor Steven Clifford et al. | The TP53-ARF tumor suppressor pathway is frequently disrupted in large/cell anaplastic medulloblastoma | 2004 |
|
Dr Jackie Langdon Roberto Hernan Dr Richard Gilbertson Professor Steven Clifford
| Molecular analysis of the PDGFR alpha-RAS/MAPK pathway in childhood medulloblastoma | 2003 |
|
Dr Richard Gilbertson Roberto Hernan Dr Adrian Frank Professor David Ellison
| ERBB receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease | 2002 |
|
Dr Richard Gilbertson Roberto Hernan Emeritus Professor Robert Perry Professor John Lunec Professor Andrew Pearson et al. | Clinical and molecular stratification of disease risk in medulloblastoma | 2001 |
|
Dr Richard Gilbertson Roberto Hernan Professor David Ellison Emeritus Professor Robert Perry Professor Andrew Pearson et al. | Novel ERBB4 juxtamembrane splice variants are frequently expressed in childhood medulloblastoma | 2001 |
|
Dr Richard Gilbertson Roberto Hernan Professor Andrew Pearson Professor John Lunec
| Expression and characterisation of novel ErbB-4 alternative spliced variants by childhood | 1999 |
|
Dr Richard Gilbertson Roberto Hernan Professor Andrew Pearson Professor John Lunec
| The ErbB2 receptor represents a potential target for novel therapies in childhood medulloblastoma. | 1999 |
|